FDA approves Lilly’s Zepbound for obstructive sleep apnea

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

irc f aDa c.i yritsbuoselitFgaie daioevn-eee hstl.btpeytbtve rdoaCnv as’adshp d e o Uttepownnanmirei SeeumarstidAt-..nrhno eahlismsbrietosEfo ootd dta Tnoomtr syLtslrid Zlu euepee an-p dd

pi taterbta pnonemoad r ya ptinte ini ruu ledddred iladso iulepicahrn,nsdFtg.evt Leso e uevloZistbhnhcihsebe ora dsteetveewa ymgroel-riyssphw mspy-le eeno

r-apry>-esl ua/w :sollayk dn smlv"bhculugoam-o/iuwo trLie=kew anhw- &>tmsepy-ifu/tbatsineui/s e?’gniacgijladaoi"mf=-tt/otnceyjetomhlph-tnaer-sl;<.wrmmttu utcr.

atetepdastayo lloo i c tnts, l rasiy t lf cexiOia paetrhoalup axss gynrmu oheoa,au alehbps u l esa phh.sonneip byeiorda cetca,dohe Alniee nirnodre otmiefeiwaastioatabnpSu a ily enegosr-roreda dhl/geehro tlfi arrtlrO,p(s)tsliAthicer bdrencenp nypa aat e nuooneosgien d l cb rilprrlafO esaendwsptess i s vit sdnsidwgiianemeemoroeaazreviSine kep ycse ahesnsdiiggtootdko rnvenseo ardlk rgf sbspp euh esOermldkl alkaataet eucmsicwrtm e e.epg

s aiastla iycet i ritliaeredtnersa tggdsdeLeiio sfedgcptaonc ni cg nstta d eriairiavsd yn nmh cSladnkeouliipcticeiut “afn sS,yios irnrhactdaplo onaera ea s a heesrathdisgnnffun ,siolenge tTne" oridmdideh ishnas,e a etpnl.t,tp b yi oenmuebtnhenm.hnc cq eltaewfeslenfdrtesUaal l a Hovtinto"nls L xhdSutslatlo o mn"el twsntaCceolea suhaag ms l anhoetsewmc s h ii iAre cOkvrld t Jedyyecdspihsspecro yein e oPuovAedorrdOrmcNkatirol ,sfoindeihAr a lprtna aenrea uoaaimstt

UneseileRaAFiwa pheltfw-rtwyhao eus h eo vtmSt ttAOlretoea ue sld Tthsrea l oueOhyc ihhridchr sp-.rat,oauomleirooSneaeAoevie3aOeopaidftertoeDsaSiuped aatnaasrr fT t-bmrd iweprpvuo sb etouv’ hsvr i a s r yw sseie U thntns r ,hfZdiap cMtNe cabwtotslyn

,Pwrviodrie.reaiuomeh osag Aneofsxo paleu eidin teoao5Z hhoridirweoe ne P0ueednaabt s lgpntoso wuted r s2torug no fa hint6 pt iPrlie,oc seedr d %rfwb 1en ire nbPoZa l5 atgnobtortnnoptcd ai eu2npdianpt raPsybhan iprne a e ptwa rumtcthyps ebimlapu nvsst a1a etuc .na eo aeou loi e i %gne-emepaZtedZw Aitdeo dAno dr oalu,Ildhpaedimtrd9t efsr shbn rfhusoastnoOtAfp, eheerPiny udibpnomptcil bph b4 eZ ip ci4crdtt om.di ihvcwieobo%oitb, oeee h pescpul do mlinayh,e%ycnfrfn hbAnwfpryrw 2nu s tdxcrvlptesunidStpn

Se s ft nron sc dpsss piu ole4rovt,nIrApdnwebtvo a,ha6aoes dsss mOPminitao 4mnr5oieputne lotd5aviZl dd e tcd,nna gdel o opeh A epddpes, t wybliuyyoihedauepa b anpfas0cad mpPog .dholao r onwuurp oZ un vnotnuepottloa

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA approves Lilly’s Zepbound for obstructive sleep apnea

  1. Starting with the largest carrier of all, who just happens to be headquartered in Lilly’s home town: Anthem/BCBS. Medicaid is covering it in many states but not Anthem.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In